Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: G

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Gafni, A.
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS
Gajic-Veljanoski, O.
TRA2-4   USE OF BAYESIAN BIVARIATE RANDOM-EFFECTS META-ANALYSIS TO EXPLORE UNCERTAINTY IN THE TREATMENT EFFECT OF VITAMIN K ON BONE MINERAL DENSITY AND FRACTURES
Gallo, J.
P4-35   PATIENT CHARACTERISTICS ASSOCIATED WITH PREFERENCE PATTERNS AND MESSAGING FRAMES FOR DEPRESSION TREATMENT
Gandhi, S. K.
P2-45   COMPARING THE EFFECTIVENESS OF ATORVASTATIN AND ROSUVASTATIN FOR MANAGING ELEVATED CHOLESTEROL IN CLINICAL PRACTICE SETTINGS: A SIMULATED STUDY
Garber, A. M.
E-5   A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR PREVENTING CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Garcia, E.
P3-3   TREATMENT PREFERENCES DERIVED USING ADAPTIVE BEST-WORST CONJOINT (ABC) ANALYSIS,
P3-35   IMPACT OF A NOVEL METHOD OF PATIENT PREFERENCE ELICITATION ON DECISION QUALITY IN MEN WITH PROSTATE CANCER: PILOT DATA
Garcia, M.
B-5   PSYCHOMETRIC PROPERTIES OF A NEW MEDICAL RISK SUBSCALE FOR DOSPERT
Garg, V.
P4-56   PREDICTORS OF PROSTATE CANCER SCREENING: A MULTILEVEL MODELING APPROACH
Gartlehner, G.
F-6   USING SIMULATED DATA TO VALIDATE BAYESIAN MIXED TREATMENT COMPARISON META-ANALYSIS FOR DIFFERENT EVIDENCE NETWORK PATTERNS AND NUMBERS OF STUDIES
Gavaruzzi, T.
D-1   TESTING THE ADDED VALUE OF DECISION AID COMPONENTS TO FACILITATE PATIENTS INFORMED DECISION MAKING ABOUT DIALYSIS TREATMENT OPTIONS
Gavious, A.
TRA1-5   AN INFUENZA VACCINATION POLICY BASED ON A PREVIOUS YEAR'S ILLNESS
Gazelle, G. S.
B-1   OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR CLINICAL MANAGEMENT OF PULMONARY NODULES USING A LUNG CANCER MODEL,
L-5   COST-EFFECTIVENESS OF SCREENING RESISTANT HYPERTENSIVE PATIENTS FOR PRIMARY ALDOSTERONISM,
P3-43   IMAGING STRATEGIES FOR ACUTE APPENDICITIS: EFFECTS OF RADIATION-INDUCED CANCER RISKS
Gaziano, T.
L-3   COMPARING FIFTEEN APPROACHES OF ASSESSING CARDIOVASCULAR DISEASE RISK USING RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE ANALYSIS,
L-5   COST-EFFECTIVENESS OF SCREENING RESISTANT HYPERTENSIVE PATIENTS FOR PRIMARY ALDOSTERONISM
Gebremariam, A.
J-4   MEASURING FAMILY HRQOL SPILLOVER EFFECTS USING DIRECT HEALTH UTILITY ASSESSMENT
Gershon, R.
P4-27   INTEGRATING THE PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS) SYMPTOM ASSESSMENT INTO ROUTINE CANCER CARE
Giang, P. H.
P1-56   DECISION MAKING IN HETEROGENEOUS UNCERTAINTY ENVIRONMENT
Gierisch, J.
P1-40   NET EFFECT OF CURRENT PATTERNS OF ORAL CONTRACEPTIVE USE ON POTENTIALLY FATAL OUTCOMES IN THE UNITED STATES,
P1-41   USING NET BENEFITS AND ACCEPTABILITY CURVES TO QUANTIFY UNCERTAINTY ABOUT TRADEOFFS BETWEEN HARMS AND BENEFITS OF ORAL CONTRACEPTIVES
Gifford, A.
P1-6   COST-EFFECTIVENESS ANALYSIS OF NEW DIRECT-ACTING ANTIVIRALS (DAAS) THERAPY FOR PATIENTS WITH UNTREATED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION IN THE VETERANS HEALTH ADMINISTRATION
Giguere, A.
P3-53   IMPLEMENTING DECISION BOXES IN PRIMARY HEALTHCARE TEAMS TO FACILITATE SHARED DECISION MAKING: BARRIERS AND FACILITATORS
Gilden, J.
P4-8   A PROSECTIVE STUDY ON COSTS TO INSURANCE AND OUT-OF-POCKET COSTS OF COCHLEAR IMPLANTATION COMPARED WITH HEARING AIDS IN NEWLY IMPLANTED ADULT RECIPIENTS
Gill, S. S.
P2-36   CHOLINESTERASE INHIBITORS: A POPULATION-BASED ASSESSMENT OF RESOURCE UTILIZATION FOR PATIENTS WITH ALZHEIMER'S DEMENTIA
Gillaspie, Y.
P1-35   PROGNOSTIC MODEL OF MORTALITY FOLLOWING HUMAN INFLUENZA (A) H5N1 INFECTION
Gilmore, M. E.
B-1   OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR CLINICAL MANAGEMENT OF PULMONARY NODULES USING A LUNG CANCER MODEL,
P3-43   IMAGING STRATEGIES FOR ACUTE APPENDICITIS: EFFECTS OF RADIATION-INDUCED CANCER RISKS
Gittens, R.
D-5   NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN
Gluck, S.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Goeckenjan, G. Sr.
P2-53   META-ANALYSIS OF STUDIES COMPARING ADJUVANT CHEMOTHERAPY WITH SURGERY ALONE IN NON-SMALL CELL LUNG CANCER
Goehler, A.
B-1   OPTIMIZATION OF FOLLOW-UP GUIDELINES FOR CLINICAL MANAGEMENT OF PULMONARY NODULES USING A LUNG CANCER MODEL
Gold, H. T.
P3-4   USING SOCIAL MEDIA TO GAUGE REACTION TO THE USPSTF REPORT ON PROSTATE CANCER SCREENING: TWITTER AS AN INVESTIGATIVE TOOL,
TRA1-4   MODELING PERSONALIZED RANK ORDER OF PREVENTIVE CARE GUIDELINES
Golden, B. L.
P2-34   LONG DISTANCE TRIAGE: ASSESSING PATIENT RISK FOR INTER-HOSPITAL TRANSFER PATIENTS
Goldhaber-Fiebert, J. D.
E-3   THE COST-EFFECTIVENESS OF MRI IN THE DIAGNOSIS OF ACUTE APPENDICITIS DURING PREGNANCY: A GUIDE FOR SURGICAL DECISION-MAKING,
E-5   A COST-EFFECTIVENESS ANALYSIS OF STATINS FOR PREVENTING CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE,
F-3   COMBINING REGRESSION ANALYSES AND MARKOV MODELS TO INFER AGE-SPECIFIC MORTALITY RATES BY HEPATITIS C INFECTION AND RISK FACTOR STATUS,
I-4   CALIBRATION METHODS FOR INFERRING TRANSITION PROBABILITIES FROM CROSS-SECTIONAL STUDIES,
L-2   DYNAMIC TRANSMISSION MICROSIMULATION OF TUBERCULOSIS IN INDIA TO ASSESS THE FUTURE IMPACT OF TREATMENT PROGRAMS,
P1-2   COST-EFFECTIVENESS OF ROUTINE USE OF MAGNESIUM SULFATE FOR SEIZURE PROPHYLAXIS IN MILD PREECLAMPSIA,
P1-34   COST-EFFECTIVENESS OF TREATMENT OPTIONS FOR DIABETIC MACULAR EDEMA,
P2-48   DETERMINING OPTIMAL INFORMATIONAL INTERVENTION BUNDLES TO MAXIMIZE HEALTH OUTCOMES,
TRA2-3   THE EFFECT OF PREHOSPITAL PROVIDER TRIAGE ACCURACY ON THE COST-EFFECTIVENESS HELICOPTER SCENE TRANSPORT FOR TRAUMA,
TRA2-5   CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYING, MODIFIABLE RISK FACTORS: THE EXAMPLE OF SMOKING INITIATION AND QUITTING IN INDIA
Goldstein, M. K.
B-2   EXAMINING PARAMETERS THAT IMPACT INCREMENTAL COST-EFFECTIVENESS RATIOS
Goldstein, M. K.
P3-39   STAKEHOLDER INPUT TO CLINICAL DECISION SUPPORT (CDS) FOR COMPLEX CHRONIC DISEASE,
SYM1-2   INFORMATICS CHALLENGES IN THE MANAGEMENT OF PATIENTS WITH MULTIPLE MORBIDITIES
Gomes, M.
C-2   MULTIPLE IMPUTATION METHODS FOR HANDLING MISSING DATA IN COST-EFFECTIVENESS ANALYSES: AN APPLICATION TO CLUSTER RANDOMISED TRIALS
Gonzalez, G.
SYM2-3   NATURAL LANGUAGE PROCESSING FOR AUTOMATIC COHORT SELECTION
Gonzalez, M.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Goodman, K.
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
Goodman, M.
P2-3   ABSTRACT WITHDRAWN - ECONOMIC EVALUATION OF 21-GENE ASSAY FOR EARLY STAGE BREAST CANCER PATIENTS FROM A PERSPECTIVE OF CHINESE HEALTH CARE SYSTEM
Goodman, S.
P4-43   TRUST AND COMPARATIVE EFFECTIVENESS RESEARCH: METHODS, POLICIES, AND FUTURE DIRECTIONS FOR REPRODUCIBLE RESEARCH
Gopalappa, C.
P1-15   ESTIMATING LIFETIME HIV TREATMENT COSTS IN THE UNITED STATES: EARLY VERSUS LATE ENTRY INTO CARE
Goren, A.
P3-29   PATIENT-REPORTED SATISFACTION ON USTEKINUMAB TREATMENT COMPARED WITH PRIOR BIOLOGIC THERAPY
Gossey, J. T.
TRA1-1   IMPROVING PHYSICIAN PRESCRIBING DECISIONS THROUGH USER INTERFACE REDESIGN
Grad, R.
P3-53   IMPLEMENTING DECISION BOXES IN PRIMARY HEALTHCARE TEAMS TO FACILITATE SHARED DECISION MAKING: BARRIERS AND FACILITATORS
Granados-García, V.
P4-49   COST EFFECTIVENESS OF STRATEGIES FOR DIAGNOSIS OF HEPATITIS C IN MEXICO
Grant, G.
P3-10   ELECTRONIC REPORTING TO ASSESS AND IMPROVE VENOUS THROMBOEMBOLISM PROPHYLAXIS
Grant, P. M.
L-1   COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIRETROVIRAL THERAPY AND PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION IN SOUTH AFRICA
Green, M. J.
P4-24   RELIABILITY OF AN ONLINE DECISION AID FOR ADVANCE CARE PLANNING: AN APPLICATION OF GENERALIZABILITY THEORY
Greenes, R.
SYM2-5   LABORATORY TO PROMOTE/DEVELOP BETTER USABILITY OF CLINICAL SYSTEMS, INTERFACES, EFFECTIVENESS, AND INCORPORATION OF DECISION SUPPORT FOR IMPROVED CARE COORDINATION AND CONTINUITY
Greenhalgh, J.
P2-9   THE COST EFFECTIVENESS OF PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL DISEASE: AN ECONOMIC EVALUATION
Greenway, M.
P3-53   IMPLEMENTING DECISION BOXES IN PRIMARY HEALTHCARE TEAMS TO FACILITATE SHARED DECISION MAKING: BARRIERS AND FACILITATORS
Grieve, R.
C-2   MULTIPLE IMPUTATION METHODS FOR HANDLING MISSING DATA IN COST-EFFECTIVENESS ANALYSES: AN APPLICATION TO CLUSTER RANDOMISED TRIALS,
H-5   AN INTEGRATED APPROACH TO EVALUATING ALTERNATIVE RISK PREDICTION STRATEGIES: A CASE STUDY COMPARING ALTERNATIVE APPROACHES FOR PREVENTING INVASIVE FUNGAL DISEASE
Grigoryan, R.
P4-19   HOW DECISIONS ON TUBERCULOSIS CARE UTILIZATION AND PLACE OF WORK AMONG MIGRANT WORKERS FROM ARMENIA IMPACT TB HEALTH OUTCOMES
Groessl, E.
P1-6   COST-EFFECTIVENESS ANALYSIS OF NEW DIRECT-ACTING ANTIVIRALS (DAAS) THERAPY FOR PATIENTS WITH UNTREATED CHRONIC HEPATITIS C GENOTYPE 1 INFECTION IN THE VETERANS HEALTH ADMINISTRATION
Groothuis-Oudshoorn, K. G. M.
A-6   INTEGRATING PATIENT PREFERENCES AND CLINICAL TRIAL DATA IN A BAYESIAN MODEL FOR QUANTITATIVE RISK-BENEFIT ASSESSMENT
Grunfeld, E.
P2-28   DECISION SUPPORT NEEDS TO BE TAILORED TO THE INDIVIDUAL PATIENT: ADJUVANT ENDOCRINE THERAPY FOR POST-MENOPAUSAL WOMEN WITH RECEPTOR-POSITIVE EARLY-STAGE BREAST CANCER
Guerrier, M.
P1-17   ADOPTING CLINICAL PRACTICE GUIDELINES NEGATIVELY IMPACT SHARING DECISIONS WITH PATIENTS BUT TRAINING HEALTH PROFESSIONALS IN SDM CANCELS THIS IMPACT
Guillen, U.
P4-40   DO VALID FILM DECISION-AIDS INFORM PARENTS ON POTENTIAL OUTCOMES OF EXTREME PREMATURITY WITHOUT CREATING STRESS?
Gulati, M.
P2-34   LONG DISTANCE TRIAGE: ASSESSING PATIENT RISK FOR INTER-HOSPITAL TRANSFER PATIENTS
Guterman, J.
P3-2   AN AUTOMATED TELEPHONIC SCREENING AND MONITORING SYSTEM FOR DEPRESSION CARE MANAGEMENT: PRELIMINARY FINDINGS FROM A CLINICAL TRIAL
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z